目的 對(duì)天津中醫(yī)藥大學(xué)第一附屬醫(yī)院2019-2020年活血類中藥注射劑使用合理性進(jìn)行分析總結(jié),為臨床合理用藥提供參考。方法 通過(guò)醫(yī)院信息系統(tǒng)和Excel軟件統(tǒng)計(jì)分析2019年1月-2020年12月活血類中藥注射劑的使用情況。結(jié)果 2020年天津中醫(yī)藥大學(xué)第一附屬醫(yī)院活血類中藥注射劑應(yīng)用較2019年整體下降20.68%,但占中成藥總體金額的比例基本持平;活血類中藥注射劑2019年和2020年銷售金額與使用頻度最高的品種固定,均為注射用血栓通(凍干);2020年活血類中藥注射劑的平均日費(fèi)用整體下降,并且同步性更加合理;活血類中藥注射劑使用受到了新冠疫情的一定沖擊,但醫(yī)療政策對(duì)活血類中藥注射劑應(yīng)用的影響更大。結(jié)論 活血類中藥注射劑是醫(yī)院用藥的重要組成部分,應(yīng)用相對(duì)合理,繼續(xù)提高合理用藥水平,能夠保證其在臨床中發(fā)揮更大的作用。

Objective To analyze and summarize the use and rationality of blood-activating TCM injections in First Teaching Hospital of Tianjin University of Traditional Chinese Medicine from 2019 to 2020, so as to provide reference for rational drug use in clinic. Methods The hospital information system and Excel software were used to analyze the use of TCM injections for promoting blood circulation from January 2019 to December 2020. Results In 2020 the application of blood-activating Chinese medicine injections in our hospital decreased by 20.68% compared with 2019, but the proportion of total Chinese patent medicine was basically the same. Xueshuantong (freeze-dried) for injection is the blood activating traditional Chinese medicine injection with the highest sales amount and use frequency in 2019 and 2020. The average daily cost of blood-activating TCM injections in 2020 decreased as a whole, and the synchronization was more reasonable. Although the use of blood-activating TCM injections has been affected by COVID-19, medical policies have a greater impact on the application of traditional Chinese medicine injections. Conclusion Blood-activating traditional Chinese medicine injection is an important part of hospital medication, and its application is relatively reasonable, and continue to improve the level of rational drug use, so that it can play a greater role in clinical practice.

R286